HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H J Haisma Selected Research

adenovirus receptor

2/2005Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro.
11/2003Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.
7/2002Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer.
5/2001Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H J Haisma Research Topics

Disease

13Neoplasms (Cancer)
01/2008 - 04/2000
5Infections
06/2006 - 06/2000
3Carcinoma (Carcinomatosis)
03/2005 - 05/2001
2Colonic Neoplasms (Colon Cancer)
03/2005 - 09/2002
2Ovarian Neoplasms (Ovarian Cancer)
02/2001 - 02/2001
1Glomerulonephritis
02/2013
1Herpes Simplex
01/2008
1Prostatic Neoplasms (Prostate Cancer)
02/2005
1Melanoma (Melanoma, Malignant)
02/2005
1Cardiovascular Diseases (Cardiovascular Disease)
02/2003
1Osteosarcoma (Osteogenic Sarcoma)
09/2002
1Urinary Bladder Neoplasms (Bladder Cancer)
07/2002
1Adenocarcinoma
05/2001
1Esophageal Neoplasms (Esophageal Cancer)
05/2001
1Glioma (Gliomas)
03/2001
1Necrosis
02/2001

Drug/Important Bio-Agent (IBA)

6Epithelial Cell Adhesion MoleculeIBA
02/2006 - 02/2001
5Proteins (Proteins, Gene)FDA Link
01/2008 - 04/2000
4EnzymesIBA
06/2006 - 02/2001
4ProdrugsIBA
03/2005 - 02/2001
4adenovirus receptorIBA
02/2005 - 05/2001
3LuciferasesIBA
02/2006 - 03/2001
3AntigensIBA
02/2005 - 03/2001
3ErbB Receptors (EGF Receptor)IBA
09/2002 - 06/2000
2Antineoplastic Agents (Antineoplastics)IBA
03/2005 - 09/2002
2Irinotecan (Camptosar)FDA LinkGeneric
03/2005 - 09/2002
2Epidermal Growth Factor (EGF)IBA
07/2002 - 03/2001
2Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA
05/2001 - 03/2001
2N- (4- doxorubicin- N- carbonyl(oxymethyl)phenyl)- O- glucuronyl carbamateIBA
02/2001 - 02/2001
1E-SelectinIBA
02/2013
1Thymidine KinaseIBA
01/2008
1Ganciclovir (Cytovene)FDA LinkGeneric
01/2008
1Transaminases (Aminotransferases)IBA
06/2006
1Neoplasm Antigens (Tumor Antigens)IBA
02/2006
1Surface Antigens (Surface Antigen)IBA
03/2005
1Glycoproteins (Glycoprotein)IBA
02/2005
1CXC ChemokinesIBA
02/2005
1CXCR4 Receptors (CXCR4 Receptor)IBA
02/2005
1SurvivinIBA
02/2005
1Messenger RNA (mRNA)IBA
02/2005
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2005
1Indicators and Reagents (Reagents)IBA
02/2003
1Carboxylesterase (Hydrolase S)IBA
09/2002
1Therapeutic UsesIBA
09/2002
1Single-Chain AntibodiesIBA
07/2002
1Integrin alpha ChainsIBA
07/2002
1Complementary DNA (cDNA)IBA
02/2002
1Bispecific AntibodiesIBA
05/2001
1IntegrinsIBA
03/2001
1Monoclonal AntibodiesIBA
02/2001
1GlucuronidaseIBA
02/2001
1Pharmaceutical PreparationsIBA
02/2001
1Immunoconjugates (Immunoconjugate)IBA
02/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2001
1GlucuronidesIBA
02/2001
1LigandsIBA
06/2000

Therapy/Procedure

7Therapeutics
01/2008 - 04/2000
1Drug Therapy (Chemotherapy)
02/2001